09:18 AM EDT, 07/15/2025 (MT Newswires) -- Health care stocks were mixed premarket Tuesday with the Health Care Select Sector SPDR Fund ( XLV ) 0.2% lower and the iShares Biotechnology ETF (IBB) recently up 0.8%.

ProKidney ( PROK ) shares were up more than 12% after the company said the US Food and Drug Administration has confirmed the estimated glomerular filtration rate slope can be used as an endpoint to support a Biologics License Application for rilparencel in patients with chronic kidney disease and type 2 diabetes under the accelerated approval pathway.

Iovance Biotherapeutics ( IOVA ) said it has appointed Corleen Roche as chief financial officer, effective Aug. 6. Shares of Iovance Biotherapeutics ( IOVA ) were down nearly 7% pre-bell.

Aquestive Therapeutics ( AQST ) shares were up nearly 3% after the company said Health Canada has granted a meeting with the company in Q3 to discuss the latter's planned new drug submission for Anaphylm sublingual film, an orally injected emergency treatment for serious allergic reactions, including anaphylaxis.